-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Thirty and Full of "Power" — Keyuan Pharmaceutical & Linuo Pharmaceutical Win Multiple Honors at Linuo Group's 30th Anniversary Celebration!
Publish Time:
2024-09-08
At 30, we stand firm with vibrant energy, steadily moving forward with practical action toward the future! On September 28, Linuo Group celebrated a significant milestone in its remarkable journey—its 30th anniversary.
At 30, we stand firm with vibrant vitality, steadily moving forward with practical action toward the future! On September 28, Linuo Group celebrated a significant milestone in its remarkable journey—its 30th anniversary.
At this grand celebration, key members of the group's Greater Health Industry sector—Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical—were honored with multiple prestigious awards, including "Advanced Company" and "Outstanding Team for Safe Production," in recognition of their outstanding performance and remarkable contributions.
20 Years of Brilliance, Building the Future Together
As the second listed company under the Linuo Group, Keyuan Pharmaceutical and Linuo Pharmaceutical have accumulated profound R&D capabilities and innovative strength over two decades of development. Actively embracing the "Belt and Road" initiative, they have deepened collaborations with numerous domestic and international pharmaceutical companies and research institutions, steadily advancing toward capitalization and globalization.
At the celebration, the Group grandly held its 2023 Annual Recognition Ceremony, during which Keyuan Pharmaceutical & Linuo Pharmaceutical were honored with the title of "Advanced Company." This collective accolade not only recognizes the company's achievements over the past year but also serves as a source of inspiration and encouragement for future growth and development.
Recognizing Outstanding Achievements: Staying True to Our Original Aspiration, Forging a Strong and Resilient Team
After recognizing the outstanding contributions of the team, the group also selected and honored exceptional individuals who achieved remarkable results. Awards such as the "30th Anniversary Merit Award," "Outstanding Management Award," "Business Support Excellence Award," "R&D Star," and "Service Star" were presented one after another. In total, more than 100 employees from Keyuan Pharmaceutical and Linuo Pharmaceutical received various prestigious accolades, highlighting the team's strong sense of unity and its significant impact and dedication.
Innovation empowers, walking together to embark on a new journey.
Lilun Group's 30 years of steadfast development have spearheaded the remarkable journey of Koyuan Pharmaceutical & Lilun Pharmaceutical—from their inception to their current thriving growth. The company has consistently upheld the spirit of "serving the nation through industry and pursuing excellence," firmly committing to technological innovation and quality-driven practices, while continuously driving both product and industrial upgrades.
In the future, Keyuan Pharmaceutical and Linuo Pharmaceutical will continue to deeply pursue their "One Core, Two Wings, Three Pillars" development strategy, strengthening efforts across the entire R&D, production, and distribution chain. Driven by technology-driven innovation as the leader, digital and intelligent manufacturing as the cornerstone, and culturally infused marketing as the engine of growth, we will relentlessly seek new growth opportunities and market prospects. At the same time, we will actively fulfill our social responsibilities, building a pioneering Chinese brand in digital and intelligent pharmaceutical innovation, and contributing our wisdom and strength to the realization of Healthy China.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline